Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
The Alzheimer’s Association leads the way toward ending Alzheimer’s and all other dementia. Donate today so we can continue accelerating critical research and providing 24/7 support during this global emergency and beyond.
As disease-modifying therapies become available, initiating therapy early in the disease, before clinical signs emerge, will be critical, so research on new strategies for earlier diagnosis is among the most active areas in Alzheimer's science.
Although there are no validated biomarkers for Alzheimer's disease, researchers are investigating genetic risk profiling, cerebrospinal fluid biomarkers, such as beta-amyloid and tau, and advanced brain imaging techniques that will allow clinicians to detect and monitor genetic, metabolic, vascular and cellular changes related to Alzheimer's disease.